APA (7th ed.) Citation

JD, K., LH, C., BF, L., K, K., F, X., JC, F., & S, W. (2022). MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis. Cell biology international, 46(12), 2085. https://doi.org/10.1002/cbin.11894

Chicago Style (17th ed.) Citation

JD, Kai, Cheng LH, Li BF, Kang K, Xiong F, Fu JC, and Wang S. "MYH9 Is a Novel Cancer Stem Cell Marker and Prognostic Indicator in Esophageal Cancer That Promotes Oncogenesis Through the PI3K/AKT/mTOR Axis." Cell Biology International 46, no. 12 (2022): 2085. https://doi.org/10.1002/cbin.11894.

MLA (9th ed.) Citation

JD, Kai, et al. "MYH9 Is a Novel Cancer Stem Cell Marker and Prognostic Indicator in Esophageal Cancer That Promotes Oncogenesis Through the PI3K/AKT/mTOR Axis." Cell Biology International, vol. 46, no. 12, 2022, p. 2085, https://doi.org/10.1002/cbin.11894.